TY - JOUR
T1 - APLAR rheumatoid arthritis treatment recommendations
AU - Lau, Chak Sing
AU - Chia, Faith
AU - Harrison, Andrew
AU - Hsieh, Tsu Yi
AU - Jain, Rahul
AU - Jung, Seung Min
AU - Kishimoto, Mitsumasa
AU - Kumar, Ashok
AU - Leong, Khai Pang
AU - Li, Zhanguo
AU - Lichauco, Juan Javier
AU - Louthrenoo, Worawit
AU - Luo, Shue Fen
AU - Nash, Peter
AU - Ng, Chin Teck
AU - Park, Sung Hwan
AU - Suryana, Bagus Putu Putra
AU - Suwannalai, Parawee
AU - Wijaya, Linda Kurniaty
AU - Yamamoto, Kazuhiko
AU - Yang, Yue
AU - Yeap, Swan Sim
N1 - Publisher Copyright:
© 2015 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.
PY - 2015/9/1
Y1 - 2015/9/1
N2 - Aims: Rheumatoid arthritis is a chronic inflammatory condition that affects approximately 1% of the world's population. There are a wide number of guidelines and recommendations available to support the treatment of rheumatoid arthritis; however, the evidence used for these guidelines is predominantly based on studies in Caucasian subjects and may not be relevant for rheumatoid arthritis patients in the Asia-Pacific region. Therefore, the Asia Pacific League of Associations for Rheumatology established a Steering Committee in 2013 to address this issue. Materials and methods: The AGREE II instrument and the ADAPTE Collaboration framework were applied to systematically identify, appraise, synthesize, and adapt international rheumatoid arthritis guidelines for use in the Asia-Pacific region. Results: Forty rheumatoid arthritis treatment recommendations, based on evidence and expert opinion, were drafted and are presented in this report. Conclusion: The Asia Pacific of Associations for Rheumatology rheumatoid arthritis treatment recommendations are intended to serve as a reference for best practice management of rheumatoid arthritis in Asia-Pacific, focusing on local issues to ensure the delivery of basic care for these patients, and to improve their outcomes. In addition, the document will serve as a reference for national rheumatology associations in Asia-Pacific for developing guidelines in their respective countries.
AB - Aims: Rheumatoid arthritis is a chronic inflammatory condition that affects approximately 1% of the world's population. There are a wide number of guidelines and recommendations available to support the treatment of rheumatoid arthritis; however, the evidence used for these guidelines is predominantly based on studies in Caucasian subjects and may not be relevant for rheumatoid arthritis patients in the Asia-Pacific region. Therefore, the Asia Pacific League of Associations for Rheumatology established a Steering Committee in 2013 to address this issue. Materials and methods: The AGREE II instrument and the ADAPTE Collaboration framework were applied to systematically identify, appraise, synthesize, and adapt international rheumatoid arthritis guidelines for use in the Asia-Pacific region. Results: Forty rheumatoid arthritis treatment recommendations, based on evidence and expert opinion, were drafted and are presented in this report. Conclusion: The Asia Pacific of Associations for Rheumatology rheumatoid arthritis treatment recommendations are intended to serve as a reference for best practice management of rheumatoid arthritis in Asia-Pacific, focusing on local issues to ensure the delivery of basic care for these patients, and to improve their outcomes. In addition, the document will serve as a reference for national rheumatology associations in Asia-Pacific for developing guidelines in their respective countries.
KW - Drug treatment
KW - Rheumatoid arthritis
UR - https://www.scopus.com/pages/publications/84940744778
U2 - 10.1111/1756-185X.12754
DO - 10.1111/1756-185X.12754
M3 - Article
C2 - 26334449
AN - SCOPUS:84940744778
SN - 1756-1841
VL - 18
SP - 685
EP - 713
JO - International Journal of Rheumatic Diseases
JF - International Journal of Rheumatic Diseases
IS - 7
ER -